Related Experiment Videos

Uric acid-to-HDL cholesterol ratio and incident stroke: Competing-risk models in the China Health and Retirement

Yilin Liang1, Runzhui Lin2, Yingying Deng3

  • 1Department of Neurology, Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China.

Medicine
|August 15, 2026
PubMed

Insights

Higher uric acid-to-high-density lipoprotein cholesterol ratio (UHR) is linked to increased stroke risk. This prospective study in China found UHR may help identify individuals at higher risk for stroke.

Area of Science:

  • Cardiovascular Epidemiology
  • Biomarker Research
  • Public Health

Background:

  • Cross-sectional studies suggest a link between the uric acid-to-high-density lipoprotein cholesterol ratio (UHR) and stroke.
  • Prospective cohort evidence for this association is limited, necessitating further investigation.

Purpose of the Study:

  • To investigate the association between UHR and incident stroke in a prospective cohort.
  • To evaluate UHR as a potential biomarker for stroke risk stratification.

Main Methods:

  • Prospective cohort study using data from the China Health and Retirement Longitudinal Study (CHRLS).
  • Incident stroke was tracked over a median of 9 years using self-reported physician diagnosis.
  • Fine-Gray subdistribution hazard models were employed, accounting for death as a competing event.

Main Results:

  • Higher UHR was associated with a modestly increased risk of incident stroke (sHR per 10-unit increase: 1.13; 95% CI, 1.02-1.27).
  • The highest UHR quartile showed a significantly higher stroke risk compared to the lowest quartile (sHR: 1.28; 95% CI, 1.06-1.55).
  • Clustering analysis identified a distinct group (C2) with higher stroke risk compared to another group (C1) (sHR: 1.19; 95% CI, 1.03-1.38).

Conclusions:

  • Elevated UHR is associated with a modestly increased risk of incident stroke in a Chinese population.
  • UHR may serve as a valuable tool for stroke risk stratification in community settings.
  • Further validation with adjudicated outcomes and stroke subtype data is warranted.